Wrist surgery pain breakthrough? lower anesthetic dose may ease rebound pain

NCT ID NCT06950372

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 80 adults having wrist fracture surgery to see if a lower concentration of the local anesthetic ropivacaine (3.75 mg/ml vs. 7.5 mg/ml) in a nerve block affects the severity of pain when the block wears off. Participants were randomly assigned to one of the two doses and reported their pain levels and medication use for up to 6 weeks after surgery. The goal is to find the best dose to minimize rebound pain while still providing good pain control during the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ropivacaine
What this could lead to
If it works, this could help doctors choose the best dose of local anesthetic to reduce severe pain after wrist surgery.
What could go wrong
This is a small, completed trial with only 80 participants. The results may not apply to everyone, and the lower dose might not control pain as well during surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIUS FRACTURE DISTAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

radius fracture Wrist Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Oslo University Hospital

    Oslo, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.